The atorvastatin group found no serious adverse reactions.

阿托伐他汀组未发现严重的不良反应。

Carotid artery atherosclerosis; Atorvastatin calcium; Conventional treatment.

颈动脉粥样硬化；阿托伐他汀钙；常规治疗。

Conclusion Atorvastatin is similar in curative effect and safety to Xuezhikang.

结论血脂康与阿托伐他汀降脂疗效与安全性相似。

CONCLUSION: Atorvastatin can increase ABCA1 mediated intracellular cholesterol efflux.

结论：阿托伐他汀促进ABCA1介导的细胞内胆固醇外流。

Conclusions: Atorvastatin may improve heart function of patients with DCM heart failure.

结论：托伐他汀可进一步改善DC M心力衰竭患者的心功能。